T1	Participants 84 117	patients with malignant neoplasm]
T2	Participants 207 239	patients with malignant neoplasm
T3	Participants 275 286	51 patients
T4	Participants 383 442	48 healthy adults were also studied as normal control group
T5	Participants 997 1017	patients with cancer
